_id
6915f1abbc934aba376b20c6
Ticker
RTGN
Name
RetinalGenix Technologies Inc
Exchange
OTCQB
Address
409 Apollo Beach Boulevard, Apollo Beach, FL, United States, 33572
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://retinalgenix.com
Description
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Last Close
3.2
Volume
-
Current Price
3.2
Change
0
Last Updated
2026-01-06T10:32:46.904Z
Image
data:image/webp;base64,UklGRkABAABXRUJQVlA4IDQBAADwCQCdASpAAEAAPrVSnkonJSKhsBYJAOAWiWQA0Eaq0zfyiBAOY51CsF2djhumlgCYeN6PaATq5TSJCEFQWdXuYRgaBzigeAEgGYCdmqw45yJikuuCedoAAP76Xi2bCszkx61msRg6wCE/n2UAuoHHy/uQn4/Z9/rC9o7JkFkwL/ddpH9APYf7HPe+AY+nXITtDHvqnk5HTfngf/YOYUIJJ9wuW3xkZ9LxNHIaR0ydwzUusb3NHbnJYU/ZmBGkU5sHb0po3m+ZfjY5PBaTa2fCQYErH3fMEoX+QEZtYPz59or5pzZBZyk6f0rVx8YiYawc3XDDS+Vr3dR55WwO2U0qrLcpbsotIVVezsAEn3atPOd3HKQ1jsB3r5VFqU94I/7EyjzhXvaxTQIXVuvDMUbZkaAAAA==
Ipo Date
-
Market Cap
59535872
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.995
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
567833
Operating Income
-567833
Interest Expense
958
Pretax Income
-568791
Net Income
-568791
Eps
-0.030572007111436567
Dividends Per Share
-
Shares Outstanding
18604961
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
92
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
92
Property Plant Equipment
4914
Total Assets
7001
Payables
1037632
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2179731
Equity
-2172730
Bs_currency_symbol
USD
Depreciation
640
Change In Working Capital
21713
Cash From Operations
-103837
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
103090
Net Change In Cash
-747
Cf_currency_symbol
USD
PE
-
PB
-27.4014144417392
ROE
26.17863241175848
ROA
-8124.425082131124
FCF
-103837
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
567833
Quarters > 0 > income Statement > operating Income
-567833
Quarters > 0 > income Statement > interest Expense
958
Quarters > 0 > income Statement > pretax Income
-568791
Quarters > 0 > income Statement > net Income
-568791
Quarters > 0 > income Statement > eps
-0.030572007111436567
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
18604961
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
92
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
92
Quarters > 0 > balance Sheet > property Plant Equipment
4914
Quarters > 0 > balance Sheet > total Assets
7001
Quarters > 0 > balance Sheet > payables
1037632
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2179731
Quarters > 0 > balance Sheet > equity
-2172730
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-568791
Quarters > 0 > cash Flow > depreciation
640
Quarters > 0 > cash Flow > change In Working Capital
21713
Quarters > 0 > cash Flow > cash From Operations
-103837
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
103090
Quarters > 0 > cash Flow > net Change In Cash
-747
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.030572007111436567
Quarters > 0 > ratios > PB
-27.4014144417392
Quarters > 0 > ratios > ROE
26.17863241175848
Quarters > 0 > ratios > ROA
-8124.425082131124
Quarters > 0 > ratios > FCF
-103837
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
648348
Quarters > 1 > income Statement > operating Income
-648348
Quarters > 1 > income Statement > interest Expense
1070
Quarters > 1 > income Statement > pretax Income
-649418
Quarters > 1 > income Statement > net Income
-649418
Quarters > 1 > income Statement > eps
-0.03498921931969891
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
18560517
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
839
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
839
Quarters > 1 > balance Sheet > property Plant Equipment
5554
Quarters > 1 > balance Sheet > total Assets
8388
Quarters > 1 > balance Sheet > payables
1016685
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1989553
Quarters > 1 > balance Sheet > equity
-1981165
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-649418
Quarters > 1 > cash Flow > depreciation
671
Quarters > 1 > cash Flow > change In Working Capital
94111
Quarters > 1 > cash Flow > cash From Operations
-139072
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
136200
Quarters > 1 > cash Flow > net Change In Cash
-2872
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.03498921931969891
Quarters > 1 > ratios > PB
-29.979155900694796
Quarters > 1 > ratios > ROE
32.779601900901746
Quarters > 1 > ratios > ROA
-7742.226990939437
Quarters > 1 > ratios > FCF
-139072
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
175828
Quarters > 2 > income Statement > gross Profit
-175828
Quarters > 2 > income Statement > operating Expenses
586350
Quarters > 2 > income Statement > operating Income
-586350
Quarters > 2 > income Statement > interest Expense
909
Quarters > 2 > income Statement > pretax Income
-587259
Quarters > 2 > income Statement > net Income
-587259
Quarters > 2 > income Statement > eps
-0.0317055202932466
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
18522295
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3711
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3711
Quarters > 2 > balance Sheet > property Plant Equipment
6225
Quarters > 2 > balance Sheet > total Assets
11931
Quarters > 2 > balance Sheet > payables
923340
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1679867
Quarters > 2 > balance Sheet > equity
-1667936
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-587259
Quarters > 2 > cash Flow > depreciation
666
Quarters > 2 > cash Flow > change In Working Capital
2063
Quarters > 2 > cash Flow > cash From Operations
-187222
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
184873
Quarters > 2 > cash Flow > net Change In Cash
-2349
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.0317055202932466
Quarters > 2 > ratios > PB
-35.53574237860446
Quarters > 2 > ratios > ROE
35.20872503501333
Quarters > 2 > ratios > ROA
-4922.127231581594
Quarters > 2 > ratios > FCF
-187222
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
866067
Quarters > 3 > income Statement > operating Income
-866067
Quarters > 3 > income Statement > interest Expense
960
Quarters > 3 > income Statement > pretax Income
-867027
Quarters > 3 > income Statement > net Income
-867027
Quarters > 3 > income Statement > eps
-0.0468099120546347
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
18522295
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6060
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
6060
Quarters > 3 > balance Sheet > property Plant Equipment
6891
Quarters > 3 > balance Sheet > total Assets
14946
Quarters > 3 > balance Sheet > payables
922083
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1477556
Quarters > 3 > balance Sheet > equity
-1462610
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-867027
Quarters > 3 > cash Flow > depreciation
879
Quarters > 3 > cash Flow > change In Working Capital
37320
Quarters > 3 > cash Flow > cash From Operations
-186390
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
113361
Quarters > 3 > cash Flow > net Change In Cash
-73029
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.0468099120546347
Quarters > 3 > ratios > PB
-40.52436671429842
Quarters > 3 > ratios > ROE
59.279438811439825
Quarters > 3 > ratios > ROA
-5801.063829787234
Quarters > 3 > ratios > FCF
-186390
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
703930
Annuals > 0 > income Statement > gross Profit
-703930
Annuals > 0 > income Statement > operating Expenses
4316987
Annuals > 0 > income Statement > operating Income
-4316987
Annuals > 0 > income Statement > interest Expense
3840
Annuals > 0 > income Statement > pretax Income
-4320827
Annuals > 0 > income Statement > net Income
-4320827
Annuals > 0 > income Statement > eps
-0.233277085803892
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
18522295
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6060
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
6060
Annuals > 0 > balance Sheet > property Plant Equipment
6891
Annuals > 0 > balance Sheet > total Assets
14946
Annuals > 0 > balance Sheet > payables
922083
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1477556
Annuals > 0 > balance Sheet > equity
-1462610
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-4320827
Annuals > 0 > cash Flow > depreciation
954
Annuals > 0 > cash Flow > change In Working Capital
188851
Annuals > 0 > cash Flow > cash From Operations
-741936
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
747996
Annuals > 0 > cash Flow > net Change In Cash
6060
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.233277085803892
Annuals > 0 > ratios > PB
-40.52436671429842
Annuals > 0 > ratios > ROE
295.418942848743
Annuals > 0 > ratios > ROA
-28909.587849591866
Annuals > 0 > ratios > FCF
-741936
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
403658
Annuals > 1 > income Statement > gross Profit
-403658
Annuals > 1 > income Statement > operating Expenses
2087049
Annuals > 1 > income Statement > operating Income
-2087049
Annuals > 1 > income Statement > interest Expense
3840
Annuals > 1 > income Statement > pretax Income
-2090889
Annuals > 1 > income Statement > net Income
-2090889
Annuals > 1 > income Statement > eps
-0.11856151559940706
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
17635478
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
0
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
0
Annuals > 1 > balance Sheet > property Plant Equipment
156
Annuals > 1 > balance Sheet > total Assets
156
Annuals > 1 > balance Sheet > payables
884920
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1405813
Annuals > 1 > balance Sheet > equity
-1405657
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2090889
Annuals > 1 > cash Flow > depreciation
100
Annuals > 1 > cash Flow > change In Working Capital
413280
Annuals > 1 > cash Flow > cash From Operations
-451661
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
451623
Annuals > 1 > cash Flow > net Change In Cash
-38
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.11856151559940706
Annuals > 1 > ratios > PB
-40.14743966700269
Annuals > 1 > ratios > ROE
148.7481654486123
Annuals > 1 > ratios > ROA
-1340313.4615384615
Annuals > 1 > ratios > FCF
-451661
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
370523
Annuals > 2 > income Statement > gross Profit
-370523
Annuals > 2 > income Statement > operating Expenses
3908850
Annuals > 2 > income Statement > operating Income
-3908850
Annuals > 2 > income Statement > interest Expense
5140
Annuals > 2 > income Statement > pretax Income
-3913990
Annuals > 2 > income Statement > net Income
-3913990
Annuals > 2 > income Statement > eps
-0.2266074405706863
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
17272116
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-3908799
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-2032889
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
38
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
38
Annuals > 2 > balance Sheet > property Plant Equipment
256
Annuals > 2 > balance Sheet > total Assets
294
Annuals > 2 > balance Sheet > payables
911172
Annuals > 2 > balance Sheet > short Term Debt
49000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1069357
Annuals > 2 > balance Sheet > equity
-1069063
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3913990
Annuals > 2 > cash Flow > depreciation
51
Annuals > 2 > cash Flow > change In Working Capital
230338
Annuals > 2 > cash Flow > cash From Operations
-199287
Annuals > 2 > cash Flow > capital Expenditures
307
Annuals > 2 > cash Flow > cash From Investing
-307
Annuals > 2 > cash Flow > cash From Financing
194685
Annuals > 2 > cash Flow > net Change In Cash
-4909
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.2266074405706863
Annuals > 2 > ratios > PB
-51.700200268833555
Annuals > 2 > ratios > ROE
366.11406437225867
Annuals > 2 > ratios > ROA
-1331289.1156462585
Annuals > 2 > ratios > FCF
-199594
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
361580
Annuals > 3 > income Statement > gross Profit
-361580
Annuals > 3 > income Statement > operating Expenses
2176675
Annuals > 3 > income Statement > operating Income
-2176675
Annuals > 3 > income Statement > interest Expense
2619
Annuals > 3 > income Statement > pretax Income
-2179294
Annuals > 3 > income Statement > net Income
-2179294
Annuals > 3 > income Statement > eps
-0.15258689873363657
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
14282314
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-680293
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
4947
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
4947
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
4947
Annuals > 3 > balance Sheet > payables
251282
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
469622
Annuals > 3 > balance Sheet > equity
-464675
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2179294
Annuals > 3 > cash Flow > depreciation
51
Annuals > 3 > cash Flow > change In Working Capital
156257
Annuals > 3 > cash Flow > cash From Operations
-1166971
Annuals > 3 > cash Flow > capital Expenditures
307
Annuals > 3 > cash Flow > cash From Investing
-307
Annuals > 3 > cash Flow > cash From Financing
1169699
Annuals > 3 > cash Flow > net Change In Cash
2728
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.15258689873363657
Annuals > 3 > ratios > PB
-98.35563522892345
Annuals > 3 > ratios > ROE
468.993167267445
Annuals > 3 > ratios > ROA
-44052.840105114214
Annuals > 3 > ratios > FCF
-1167278
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.030572007111436567
Valuation > metrics > PB
-27.4014144417392
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
26.17863241175848
Profitability > metrics > ROA
-618251.0869565217
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-592.7275574112734
Risk > final Score
-2341
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.00008866341824461852
Liquidity > metrics > Quick Ratio
0.00008866341824461852
Liquidity > final Score
10
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-2394
Prev Risks > 1
-2550
Prev Risks > 2
-3579
Prev Liquidities > 0
10
Prev Liquidities > 1
10
Prev Liquidities > 2
10
Updated At
2026-01-20T22:30:39.388Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0306
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0354
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0317
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0476
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0359
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0372
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1214
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0307
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0397
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0204
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0296
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0391
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.1512
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0247
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0264
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A50,000 eye scans reveal health clues fueling RetinalGenix AI imaging push Stock Titan
Read more →Understanding Real-Time Gross Settlement (RTGS) and Its Impact on Banking Investopedia
Read more →(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of RetinalGenix Technologies Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0306
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.